Back to medical news
Medical Xpress
Imaging-based modalities compared for identifying at-risk MASH
October 16, 2026
Original source summary
FibroScan-aspartate aminotransferase (FAST) demonstrated the highest sensitivity for ruling out at-risk metabolic dysfunction-associated steatohepatitis (MASH), according to a study published in the October issue of the American Journal of Gastroenterology.
Verbatim from Medical Xpress's own feed — "Imaging-based modalities compared for identifying at-risk MASH"
Want more like this?
Browse more from the feed. A free account unlocks the full feed, saving and communities.
More medical news